Radioactive Drugs Research Comment Period Reopened By FDA
This article was originally published in The Pink Sheet Daily
Executive Summary
The agency will accept comments for 60 days on its regulation of radioactive drugs for certain research uses. The additional comment period will allow for feedback in the context of a draft guidance on exploratory INDs released in April, FDA says.